Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael K Turgeon

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Surgical Oncology|June 1, 2021
Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?Michael K Turgeon, Rachel M Lee, Jessica M Keilson, et al.
Journal of Surgical Oncology|June 14, 2022
Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysisAleeza J Leder Macek, Annie Wang, Michael K Turgeon, et al.
The Journal of Surgical Research|September 1, 2021
Clinical Presentation Patterns and Survival Outcomes of Hispanic Patients With Gastric CancerGerardo A Vitiello, Leena Hani, Annie Wang, et al.
British Journal of Cancer|August 5, 2020
Suppressive myeloid cells are expanded by biliary tract cancer-derived cytokines in vitro and associate with aggressive diseaseMichael B Ware, Mohammad Y Zaidi, Jennifer Yang, et al.
Annals of Surgical Oncology|May 8, 2020
The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPECMichael K Turgeon, Adriana C Gamboa, Rachel M Lee, et al.
Journal of Surgical Oncology|August 10, 2021
A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma CollaborativeRachel M Lee, Cecilia G Ethun, Adriana C Gamboa, et al.
Journal of Surgical Oncology|October 1, 2020
A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPECRachel M Lee, Adriana C Gamboa, Michael K Turgeon, et al.
Annals of Surgical Oncology|October 16, 2024
Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular CarcinomaFrances J Bennett, Jessica M Keilson, Michael K Turgeon, et al.
Annals of Surgical Oncology|July 23, 2020
Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC CollaborativeAdriana C Gamboa, Rachel M Lee, Michael K Turgeon, et al.
Annals of Surgery|September 10, 2021
Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver TransplantationMichael K Turgeon, Shimul A Shah, Aaron M Delman, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Surgical Oncology|June 1, 2021
Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?Michael K Turgeon, Rachel M Lee, Jessica M Keilson, et al.
Journal of Surgical Oncology|June 14, 2022
Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysisAleeza J Leder Macek, Annie Wang, Michael K Turgeon, et al.
The Journal of Surgical Research|September 1, 2021
Clinical Presentation Patterns and Survival Outcomes of Hispanic Patients With Gastric CancerGerardo A Vitiello, Leena Hani, Annie Wang, et al.
British Journal of Cancer|August 5, 2020
Suppressive myeloid cells are expanded by biliary tract cancer-derived cytokines in vitro and associate with aggressive diseaseMichael B Ware, Mohammad Y Zaidi, Jennifer Yang, et al.
Annals of Surgical Oncology|May 8, 2020
The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPECMichael K Turgeon, Adriana C Gamboa, Rachel M Lee, et al.
Journal of Surgical Oncology|August 10, 2021
A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma CollaborativeRachel M Lee, Cecilia G Ethun, Adriana C Gamboa, et al.
Journal of Surgical Oncology|October 1, 2020
A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPECRachel M Lee, Adriana C Gamboa, Michael K Turgeon, et al.
Annals of Surgical Oncology|October 16, 2024
Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular CarcinomaFrances J Bennett, Jessica M Keilson, Michael K Turgeon, et al.
Annals of Surgical Oncology|July 23, 2020
Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC CollaborativeAdriana C Gamboa, Rachel M Lee, Michael K Turgeon, et al.
Annals of Surgery|September 10, 2021
Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver TransplantationMichael K Turgeon, Shimul A Shah, Aaron M Delman, et al.
Pageof 3